Literature DB >> 19243019

Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.

Rong Lin1, Xiaofeng Wang, Yi Wang, Feng Zhang, Ying Wang, Wenqing Fu, Ting Yu, Shilin Li, Momiao Xiong, Wei Huang, Li Jin.   

Abstract

Numerous studies have shown that the (TA)n repeat polymorphism in the uridine diphosphate glycosyltransferase 1 (UGT1A1) gene promoter is associated with hyperbilirubinemia. Several studies also indicated that single nucleotide polymorphism (SNP) rs4148323:G>A at Exon 1 of UGT1A1 is associated with hyperbilirubinemia. However, it remains unclear what role the polymorphisms play in influencing serum total bilirubin (TBIL) levels in general populations, and whether polymorphisms in other genes involved in the bilirubin metabolism pathway are associated with TBIL levels. The present study addressed these questions by investigating the association of four bilirubin metabolism genes with TBIL levels in three Asian populations: 11 genetic polymorphisms in heme oxygenase-1 (HMOX1); biliverdin reductase A (BLVRA); solute carrier organic anion transporter family member 1B1 (SLCO1B1); and UGT1A1. The populations consisted of 502 Kazak herdsmen, 769 Uyghur farmers, and 789 Han farmers, with distinct genetic backgrounds. UGT1A1 was found to be associated with the (TA)(7) allele of the (TA)n repeat polymorphism. We also showed that the A allele of SNP rs4148323:G>A was strongly associated with high TBIL levels in all three populations (each P<0.005). Among polymorphisms in other genes, only the (GT)n repeat polymorphism in the HMOX1 promoter region showed association with TBIL levels in the Uyghur population, but not in the Han and Kazak populations. We also assessed the contributions of (TA)n polymorphism and rs4148323:G>A to phenotypic variations in all three populations. Finally, we observed that significant differences of TBIL levels existed among the three populations; however, this could not be completely explained by the differences at the (TA)n repeat polymorphism and SNP rs4148323:G>A. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19243019     DOI: 10.1002/humu.20895

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  10 in total

Review 1.  Heme oxygenase-1 promoter polymorphisms: do they modulate neonatal hyperbilirubinemia?

Authors:  M Kaplan; R J Wong; D K Stevenson
Journal:  J Perinatol       Date:  2017-02-16       Impact factor: 2.521

2.  Association of UGT1A1 variants and hyperbilirubinemia in breast-fed full-term Chinese infants.

Authors:  Youyou Zhou; San-nan Wang; Hong Li; Weifeng Zha; Xuli Wang; Yuanyuan Liu; Jian Sun; Qianqian Peng; Shilin Li; Ying Chen; Li Jin
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

3.  Multiple Genetic Modifiers of Bilirubin Metabolism Involvement in Significant Neonatal Hyperbilirubinemia in Patients of Chinese Descent.

Authors:  Hui Yang; Qian Wang; Lei Zheng; Min Lin; Xiang-bin Zheng; Fen Lin; Li-Ye Yang
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

4.  Exome-Wide Association Study Identifies New Low-Frequency and Rare UGT1A1 Coding Variants and UGT1A6 Coding Variants Influencing Serum Bilirubin in Elderly Subjects: A Strobe Compliant Article.

Authors:  Abderrahim Oussalah; Paolo Bosco; Guido Anello; Rosario Spada; Rosa-Maria Guéant-Rodriguez; Céline Chery; Pierre Rouyer; Thomas Josse; Antonino Romano; Maurizzio Elia; Jean-Pierre Bronowicki; Jean-Louis Guéant
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

5.  Influences of APOA5 variants on plasma triglyceride levels in Uyghur population.

Authors:  Shuyuan Li; Bin Hu; Yi Wang; Di Wu; Li Jin; Xiaofeng Wang
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

6.  Association between UGT1A1 Polymorphism and Risk of Laryngeal Squamous Cell Carcinoma.

Authors:  Hui Huangfu; Hong Pan; Binquan Wang; Shuxin Wen; Rui Han; Li Li
Journal:  Int J Environ Res Public Health       Date:  2016-01-07       Impact factor: 3.390

7.  SLCO1B1 c.388A > G variant incidence and the severity of hyperbilirubinemia in Indonesian neonates.

Authors:  Radhian Amandito; Rinawati Rohsiswatmo; Michelle Halim; Vanessa Tirtatjahja; Amarila Malik
Journal:  BMC Pediatr       Date:  2019-06-28       Impact factor: 2.125

8.  Perioperative Management of Patient with Esophageal Carcinoma and Crigler-Najjar Syndrome Type 2: A Case Report.

Authors:  Dehua Ma; Fang Chen; Xiaoyun Chen; Yu Chen
Journal:  Front Surg       Date:  2022-04-27

9.  Polymorphic variants of SLCO1B1 in neonatal hyperbilirubinemia in China.

Authors:  Jiebo Liu; Jun Long; Shaofang Zhang; Xiaoyan Fang; Yuyuan Luo
Journal:  Ital J Pediatr       Date:  2013-08-12       Impact factor: 2.638

Review 10.  The Role of Heme Oxygenase-1 Promoter Polymorphisms in Perinatal Disease.

Authors:  Ruka Nakasone; Mariko Ashina; Shinya Abe; Kenji Tanimura; Hans Van Rostenberghe; Kazumichi Fujioka
Journal:  Int J Environ Res Public Health       Date:  2021-03-29       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.